ARBs inhibit tumor cell growth by blocking signaling pathways downstream of angiotensin II Type 1 receptor (AT1R) [44,45,46], activating peroxisome proliferator-activated receptors(PPARs) [47,48,49], and inducing G0/G1 cell cycle arrest [50,51]. The gene discussed is AGTR1; the disease is neoplasm.